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Abstract Recent successes in the determination of atomic
resolution structures of integral membrane proteins have relied
on purifying the proteins from abundant natural sources. In
contrast, the majority of mammalian receptors, ion channels and
transporters need to be overexpressed to obtain sufficient
material for structural studies. This has often proved to be very
difficult. Overexpression studies on a wide range of mammalian
membrane proteins have shown that a few can be expressed
functionally in bacteria, but many others require an insect or
mammalian cell host for activity or high level expression. The
serotonin transporter, which has been expressed in all the major
hosts available, is a good example that has given insights into the
problem of overexpressing mammalian membrane proteins for
structural studies. ß 2001 Federation of European Biochemi-
cal Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
The last 2 years have been exciting in the world of mem-
brane protein structures with the structure determination at
atomic resolution of three mammalian membrane proteins:
the G protein-coupled receptor rhodopsin [1], the water chan-
nel aquaporin [2] and an ATP-dependent ion pump, the sar-
coplasmic reticulum Ca2-ATPase [3]. One of the major fac-
tors in dictating why these particular membrane proteins were
crystallised was their natural abundance, circumventing all the
di⁄culties associated with overexpression. However, the ma-
jority of medically important membrane proteins are present
in tissues at very low concentrations making overexpression a
prerequisite for structural studies. Even for proteins like rho-
dopsin an overexpression system is desirable, because the
structure of mutants will illuminate structural changes in the
photocycle leading to G protein activation. The value of such
structures in furthering ideas on the mechanism is clearly seen
in the case of bacteriorhodopsin [4,5].
So what overexpression systems have been used to produce
enough protein for crystallisation? An analysis of the mam-
malian membrane protein structures published shows that the
majority of the proteins were puri¢ed from naturally abun-
dant sources (Table 1). In contrast, many bacterial membrane
proteins were overexpressed in related bacteria; note that hal-
orhodopsin was overexpressed in Halobacteria salinarum (an
archaebacterium) and not in Escherichia coli (an eubacte-
rium). There is only a single example of an overexpressed
mammalian membrane protein, gap junctions, leading to
structural data [6], but in this instance the two-dimensional
crystals formed in vivo in the mammalian expression system;
the puri¢cation of gap junctions in milligram quantities from
this cell line would have been much more di⁄cult. This anal-
ysis agrees with the extensive survey of expression systems
performed previously [7], which concluded that, in general,
homologous expression is far better at producing functional
membrane proteins than heterologous expression. I will dis-
cuss the relative merits of expressing non-functional protein
and refolding at the end of the paper. To illustrate the prob-
lems with overexpressing mammalian membrane proteins, the
serotonin transporter will be discussed.
2. The serotonin transporter
The serotonin transporter (SERT) is an example of a mam-
malian membrane protein that has been particularly di⁄cult
to overexpress. This section will give a brief introduction to
SERT, followed by a discussion of some of the expression
systems we have tried, hopefully giving hints and ideas that
are applicable to the expression of other membrane proteins.
SERT is found in the presynaptic nerve termini where it
terminates synaptic transmission by transporting serotonin
back into the cell (reviewed in [8,9]). Uptake is driven by
utilising the Na and Cl3 gradients across the membrane.
SERT contains 12 transmembrane domains, with the N- and
C-termini intracellular. A large external loop between trans-
membrane regions 3 and 4 is N-glycosylated [10] and probably
contains an intra-loop disulphide bond [11]. SERT is the site
of action of antidepressant drugs, amphetamines and cocaine.
The availability of tightly binding inhibitors has allowed ac-
curate determination of functional expression levels, regardless
of where in the cell the transporter is situated. Western blots
have been used to determine total levels of SERT expression
and the presence of N-glycosylation.
Expression of SERT was attempted in both E. coli and in
the yeast Pichia pastoris [12]. The E. coli expression trials used
two di¡erent constructs (GST-SERT and His6-SERT), three
di¡erent promoters (tac, trc, T7), three di¡erent temperatures
(37‡C, 30‡C, 17‡C) and ¢ve di¡erent E. coli strains. Although
SERT could be clearly observed on Western blots of whole
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cell extracts at reasonable expression levels (V1 mg/l), only a
small proportion of SERT was membrane associated. Binding
assays using the inhibitor imipramine did not detect any Na-
dependent high a⁄nity binding indicative of correctly folded
SERT; low a⁄nity binding not observed in the absence of
plasmid was found, but what this means in terms of SERT
structure is unclear. Expression in P. pastoris gave similar
results to expression in E. coli ; clones in two di¡erent yeast
strains (GS115, SMD1168) containing one to six copies of the
SERT cDNA were produced, but no serotonin uptake was
detected and only low a⁄nity imipramine binding was found.
Thus, in bacteria or yeast, functional expression of SERT was
not observed.
The baculovirus expression system was used to express
SERT in insect cells [10,13]. Functional SERT was detected
by both uptake of 3H-serotonin into intact cells and by
125I-RTI55 inhibitor binding assays. There were about
250 000 functional molecules of SERT per cell when grown
in shaker £asks. Changing external parameters such as me-
dium composition, multiplicity of infection or cell type did not
improve expression levels. Fusing the N-terminus of SERT to
the C-terminus of a highly expressed protein, GST, actually
led to a decrease in functional expression. The inclusion of
apoptosis inhibitors did lead to slightly better cell survival,
but expression levels were unchanged. Addition of SERT in-
hibitors to the cells also did not improve expression. The only
improvement in expression levels obtained was a result of co-
expression of the molecular chaperone calnexin, leading to a
3-fold increase in functional SERT [14,15].
One important clue to why SERT expression was problem-
atic came from a Western blot of SERT expressed in four
di¡erent insect cell lines (Sf9, Sf21, Hi5, MG1). The blot
showed that there was nearly 100 times more SERT expressed
in Hi5 and MG1 cells than in Sf21 cells, but the amount of
functional SERT loaded per lane of the gel was identical [10].
The major di¡erence between the samples was in the amount
of unglycosylated SERT, suggesting that this was inactive.
The implication was that N-glycosylation was important for
the functional expression of SERT. This hypothesis was sub-
stantiated by removing the consensus N-glycosylation sequen-
ces in SERT by altering Asn to Gln [10]. Removal of both
N-glycosylation sites led to a 20-fold decrease in functional
SERT expression. However, other factors must also be impor-
tant for SERT folding, because only about 10% of N-glyco-
sylated SERT expressed in insect cells was functional, a con-
clusion drawn from comparative Western blotting and
binding studies [14]. Despite the high level of misfolded
SERT expressed, a puri¢cation based on Ni2-a⁄nity chro-
matography produced only N-glycosylated SERT, substanti-
ating the probability that the unglycosylated transporter was
in an aggregated form in the cell (Tate, unpublished data).
Transient expression of SERT in mammalian cells, and the
creation of stable cell lines, are the systems of choice for the
analysis of mutants and the kinetic parameters for serotonin
uptake and drug binding [16,17]. However, transient systems
are di⁄cult to scale up for the production of milligrams of
protein, and the stable cell lines grow poorly and have to be
maintained under stringent selection to ensure SERT expres-
sion. One possibility for the toxicity of SERT expression is
that transport of serotonin found in the growth medium, or
the transient channel-like activity described for SERT [18],
results in signi¢cant stress for the cell, selecting against
high-expressing clones. To test this hypothesis, stable cell lines
were constructed using the EBNA-HEK293 expression system
[19,20], but the cells were maintained in the presence of SERT
inhibitors throughout the selection of clones (Tate, unpub-
lished data). No clones were obtained in the absence of inhib-
itors. Clones grown in the presence of imipramine or cocaine
expressed on average 250 000 copies per cell, but the cells grew
poorly even in the presence of the inhibitors. These ¢gures are
probably an underestimate of the actual expression levels,
because confocal microscopy showed that only about a quar-
ter of the cells expressed high levels of SERT; all the SERT
was seen at the plasma membrane, in contrast to the baculo-
virus expression system were all the SERT was in the endo-
plasmic reticulum (Tate, unpublished data). The presence of
inhibitors has clearly facilitated the generation of stable cell
lines, but the levels of expression were no higher than seen in
the baculovirus expression system.
The most promising development in expression systems
Table 1
Some recently determined three-dimensional structures of integral membrane proteinsa
Membrane protein (native source) Resolution (Aî ) Source for puri¢cation Ref.
Aquaporin-1 (human) 3.8 Human red blood cells [2]
Rhodopsin (cow) 2.8 Bovine rod outer segments [1]
Calcium pump (rabbit) 2.6 Rabbit muscle [3]
Glycerol channel, GlpF (E. coli) 2.2 OEb in E. coli [41]
Halorhodopsin (H. salinarum) 1.8 OE in H. salinarum [42]
Bacteriorhodopsin (H. salinarum) 2.0 H. salinarum [43]
Mechanosensitive channel, MscL (Mycobacterium tuberculosis) 3.5 OE in E. coli [44]
Potassium channel, KcsA (Streptomyces lividans) 3.2 OE in E. coli [45]
Photosystem II (Synechococcus elongatus) 3.8 S. elongatus [46]
Cytochrome bc1 complex (Saccharomyces cerevisiae) 2.3 S. cerevisiae [40]
Cytochrome c oxidase (cow) 2.3 Bovine heart [47]
F1F0-ATPase (S. cerevisiae) 3.9 S. cerevisiae [48]
Photosynthetic reaction centre (Rhodopseudomonas viridis) 2.3 R. viridis [49]
Fumarate reductase (Wolinella succinogenes) 2.2 W. succinogenes [50]
Nicotinic acetylcholine receptor (Torpedo marmorata) 4.6 T. marmorata [51]
Gap junctions (human) 7.5 OE in mammalian cells [6]
Na-H antiporter, NhaA (E. coli) 7.0 OE in E. coli [52]
H-ATPase (Neurospora crassa) 8 N. crassa [53]
aThis is not an inclusive list ; porin structures are not included and only a single example of many complexes are cited. See http://www.mpibp-
frankfurt.mpg.de/michel/public/memprotstruct.html for a detailed list.
bOE, overexpressed.
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over the past few years has been the introduction of inducible
expression in mammalian cells [21]. However, the disadvant-
age of these systems was either that the promoters needed to
be very weak to ensure low basal expression in the uninduced
state, or that the inducers were prohibitively expensive for
large scale expression. One system that has overcome these
problems is the cold-inducible system developed at Cytos
[22]. A stable cell line is constructed using a temperature sen-
sitive mutant replicase from the Sindbis virus and the desired
cDNA downstream. At 37‡C the viral replicase is inactive, but
from 34‡C to 29‡C there is a linear increase in activity with
decreasing temperature. We have used this system to create
stable cell lines in suspension grown mammalian cells that
express 250 000 copies per cell (Boorsma and Tate, unpub-
lished data). Further analysis of the cell line is under way to
improve the expression levels.
3. What parameters a¡ect the expression of SERT in the
various systems?
We have attempted to express SERT in all the major ex-
pression systems from bacteria to mammalian cells. The con-
clusion is that SERT cannot be functionally expressed in E.
coli or P. pastoris, but SERT is active when expressed in insect
or mammalian cells. One clear reason why expression in E.
coli may be di⁄cult is the importance of N-glycosylation in
the folding of SERT (see above). However, non-glycosylated
SERT is functional [10], so despite E. coli being unable to N-
glycosylate proteins, it should have been feasible to express
functional SERT. P. pastoris can N-glycosylate proteins, but
no functional SERT could be detected, so clearly other factors
must be important for the proper folding of SERT.
One important di¡erence between mammalian cells, yeast
and bacteria is their lipid composition. This is especially pro-
nounced in the case of sterols : mammalian cells contain
mainly cholesterol, yeasts contain mainly ergosterol and bac-
teria do not have any at all. The pertinence of sterols in SERT
expression was suggested from reconstitution experiments on
a related protein, the GABA transporter. Reconstitution in
the presence of small amounts of cholesterol increased the
initial rate of GABA uptake into the proteoliposomes by a
factor of at least 20 [23]. The tiny amounts of cholesterol
needed for this e¡ect suggested that it was interacting specif-
ically with the transporter, rather than the result being due to
non-speci¢c changes in the £uidity and thickness of the lipid
bilayer. Is cholesterol essential for SERT activity? After re-
moving cholesterol from insect cell membranes containing
functional SERT, inhibitor binding activity was signi¢cantly
reduced, but this could be partially restored by immediate
addition of cholesterol [12]. However, addition of cholesterol
analogues, such as ergosterol, did not restore binding activity.
This suggests that there is indeed a speci¢c requirement of
cholesterol for SERT functionality. The absence of cholesterol
in bacteria and yeast suggests a plausible reason for their
inability to express functional SERT.
The level of functional SERT expression, whether it is in
the baculovirus expression system, or as constitutive or induc-
ible expression in mammalian cells, seems to be relatively in-
dependent of the system used and reaches a maximum of
about 250 000 copies per cell. The only way found so far to
increase expression levels higher than this was to co-express
the molecular chaperone calnexin [14,15]. This suggests that
the folding of SERT is the slowest step in the overexpression
process. Functional expression of 250 000 copies per cell,
therefore, may represent an equilibrium between the rate of
expression and the rate of degradation. Co-expression of cal-
nexin which increases the overall rate of folding in the cell
would therefore increase expression levels. Another possibility
is that 250 000 copies per cell represent the maximum load
that the cell can tolerate in the plasma membrane without
a¡ecting the structural integrity of the cell. If this was true,
then expressing SERT targeted to the endoplasmic reticulum
might be expected to lead to higher expression levels.
4. How does SERT expression compare to other membrane
proteins?
There seems to be a spectrum of ‘express-ability’ within
membrane proteins ranging from the facile to the very di⁄-
cult. This spectrum is probably derived from a variety of con-
tributing factors including the di⁄culty of folding, rates of
degradation and toxicity to the cell. It is not clear whether
it will be possible to predict the ease of overexpressing a
particular membrane protein just from its primary sequence.
The complexity of a membrane protein might be thought to
be related to the number of transmembrane domains; this is
clearly untrue. Bacterial transporters of the major facilitator
superfamily containing 12 transmembrane domains are easily
overexpressed so that they represent 20^50% of the inner
membrane protein of E. coli [24]. In comparison, members
of the small multidrug resistance family contain only four
transmembrane regions and yet they are expressed at less
than one tenth the levels of the 12-helix transporters [25].
Another example, but this time in the baculovirus expression
system, is the 20-fold di¡erence in expression levels of the 7-
helix muscarinic G protein-coupled receptors (GPCRs) [26],
but all of these are expressed at lower levels than the 12-helix
human glucose transporter GLUT1 [27]. Further examples are
cited in Grisshammer and Tate [7].
The ‘express-ability’ spectrum should really be a log scale,
because it is often orders of magnitude more di⁄cult to ex-
press some membrane proteins compared to others. This is
particularly true when considering the expression of mamma-
lian membrane proteins in E. coli compared to expression of
bacterial membrane proteins. The most studied examples of
mammalian membrane proteins expressed in E. coli are
GPCRs [28], whose functional expression levels can be accu-
rately determined by ligand binding assays. The maximal level
of GPCR functional expression is currently 3500 copies per
cell, about 0.6 mg/l of cells [29], which is still over an order of
magnitude lower than many bacterial membrane proteins. The
reasons for this di¡erence are unclear, but probably arise at
the folding step, perhaps due to two e¡ects. Firstly, the rate of
polypeptide elongation in procaryotes [30,31] is 4^10 times
faster than in eucaryotes [32,33], and this is parallelled by
an increased rate of folding by procaryotic proteins [34] ; syn-
thesis of a mammalian polypeptide in E. coli would therefore
be much faster than normal, resulting in more polypeptide
present than usual at each stage of the folding process, which
could give rise to misfolding. Secondly, the apparatus for in-
serting membrane proteins into the membrane, the translocon,
is di¡erent in eucaryotes and procaryotes, despite some sim-
ilarities [35,36]. It is not yet clear what speci¢c interactions
there are between the translocon and a nascent polypeptide
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chain, and how these interactions may modulate the synthesis
of an integral membrane protein. It is also unknown what
e¡ect subtle di¡erences between eucaryotic and procaryotic
membrane proteins have on heterologous expression; for ex-
ample, the positive-inside rule is much less pronounced to-
wards the C-terminus of membrane proteins in eucaryotes in
comparison to procaryotes [37].
Inclusion bodies are an attractive way of producing large
amounts of protein, but this naturally requires the refolding of
the protein into a functional form before crystallisation, which
has been achieved for only relatively few membrane proteins
(reviewed in [7]). The expression level of membrane proteins
forming inclusion bodies varies depending on the protein
being expressed and factors a¡ecting expression levels have
been studied [38]. The refolding ¢eld was given hope by the
apparent refolding of a mammalian GPCR, the odorant re-
ceptor OR5 [39]. Unfortunately the hydrophobic nature of the
ligand and low a⁄nity of binding made it di⁄cult to do sat-
uration binding assays for this receptor, so it was impossible
to quantify the amount of refolded protein and to do a rig-
orous pharmacological analysis. Recently it has been claimed
that other mammalian GPCRs have been refolded (www.m-
phasys.com), but the absence of published material makes it
hard to critically evaluate the data. Clearly overexpression as
inclusion bodies and refolding is an attractive way to produce
large quantities of membrane proteins for structural studies,
but it is likely that a similar spectrum of refolding ability will
exist as it does for expression. It will be interesting to see if the
refolding and expression spectra are identical, i.e. is the easiest
membrane protein to refold also the most highly expressed in
a functional form?
5. Conclusion
The recent successes in determining the structure of integral
membrane proteins is due largely to recent advances in X-ray
crystallography and, with the realisation that it is possible, a
considerable increase in e¡ort and resources is being expended
towards other membrane proteins. However, the current state
of overexpression technology means that bacterial membrane
proteins are the most amenable for structure determination,
simply because they can often be expressed easily in large
quantities. In comparison, the overexpression of mammalian
membrane proteins in bacteria is, at best, an order of magni-
tude lower, requiring large scale growth (tens of litres) to
produce 1 or 2 mg of puri¢ed membrane protein. However,
many mammalian membrane proteins cannot be expressed in
E. coli or even in yeast. Currently these membrane proteins
require the growth of tens of litres of insect or mammalian
cells, which is extremely time consuming and costly compared
to the growth of bacteria. It may be possible to engineer
bacteria or yeast to functionally express these types of mem-
brane, but it will require alterations to many complex systems
involved in protein synthesis and folding. The refolding of
membrane proteins is creating considerable interest at the mo-
ment; it remains to be seen how applicable this will be to the
membrane proteins that are di⁄cult to express in a functional
form.
Overexpression is only the ¢rst problem encountered on the
road from cDNA sequence to the structure of a membrane
protein. The characteristics of a particular membrane protein
not only seem to dictate expression levels, but they also have a
profound e¡ect on puri¢cation and crystallisation. It is per-
haps no surprise that the membrane proteins crystallised so
far tend to be rigid and stable for a long time in many deter-
gents. The ability to rigidify supposedly £exible receptors and
transporters, by using inhibitors or conformation-dependent
antibody fragments [40], will no doubt play an important role
in the future in obtaining further membrane protein struc-
tures.
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